SI-BONE, Inc. Common Stock
SIBNStock
$17.72+1.95%52W
Market Cap$759.26M
P/E—
Div yield—
Beta0.72
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-28.85%
Price vs S&P 500 (4W)11.34%
VGM Score54.43
Market Capitalization$759.26M
Earnings Surprise History
Q1 26-0.10est. -0.19
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.20
4.20
4.20
4.20
Industry Peers — Surgical & Medical Instruments(141)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
SIBNSI-BONE, Inc. Common Stock | D | B | B | $17.72 |
| SYKStryker Corporation | C | C | D | $331.20 |
| MMM3M Company | C | F | B | $161.77 |
| BSXBoston Scientific Corp. | C | B | F | $44.62 |
| MDLNMedline Inc. Class A common stock | C | D | D | $41.11 |
| BDXBecton, Dickinson and Co. | B | C | B | $159.93 |
| DXCMDexCom, Inc. | C | B | C | $77.98 |
| RMDResMed Inc. | C | B | D | $202.76 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | $362.44 |
| SOLVSolventum Corporation | C | D | B | $81.70 |
| PENPenumbra, Inc. | F | C | B | $319.60 |
About
SI-BONE Inc. develops and markets minimally invasive surgical implants focused on spine and orthopedic conditions, including its flagship iFuse system for sacroiliac joint fusion. The company's proprietary titanium implants and surgical instruments address high-prevalence conditions such as spinal deformity, degeneration, and pelvic trauma. With operations in the U.S. and internationally, SI-BONE serves the growing orthopedic surgery market through its specialized implant portfolio.